Science Explorer Back to mapMap

Most cited papers from Merck Serono S.A. (Switzerland)

What are the most cited papers from Merck Serono S.A. (Switzerland)?

The most cited paper from Merck Serono S.A. (Switzerland) is "2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative" (Daniel Aletaha et al., 2010), with 9,731 citations. Next come "Unfolding the role of protein misfolding in neurodegenerative diseases" (1,533) and "RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation" (1,204).

Showing 50 of 60 papers. Every paper with more than 219 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative Daniel Aletaha et al. · Arthritis & Rheumatism Open access 10 Aug 2010 9,731
2 Unfolding the role of protein misfolding in neurodegenerative diseases Claudio A. Soto · Nature reviews. Neuroscience Review 2003 1,533
3 RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation Laura Codarri Deak, Gábor Gyülvészi, Vinko Toševski et al. · Nature Immunology 24 Apr 2011 1,204
4 A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis Gavin Giovannoni, Gıancarlo Comı, Stuart D. Cook et al. · New England Journal of Medicine Open access 20 Jan 2010 1,032
5 Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain Iain P. Chessell, Jonathan P. Hatcher, C. Bountra et al. · Pain 8 Feb 2005 795
6 Advances in Fmoc solid‐phase peptide synthesis Raymond Behrendt, Peter Denton White, John Offer · Journal of Peptide Science Open access 2016 776
7 Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis Montserrat Camps, Thomas Rückle, Hong Ji et al. · Nature Medicine 26 Aug 2005 756
8 HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4 Milena Schiraldi, Angela Raucci, Laura Martínez‐Muñoz et al. · The Journal of Experimental Medicine Open access 27 Feb 2012 691
9 The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: Estimates of Radiation-Related Cancer Risks Elisabeth Cardis et al. · Radiation Research 27 Mar 2007 681
10 Bax Is Present as a High Molecular Weight Oligomer/Complex in the Mitochondrial Membrane of Apoptotic Cells Bruno E. Antonsson, Sylvie Montessuit, Belén G. Sánchez et al. · Journal of Biological Chemistry Open access Apr 2001 676
11 Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries Elisabeth Cardis et al. · BMJ Open access 29 Jun 2005 606
12 Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses Kate L. Jeffrey, Montserrat Camps, Christian Rommel et al. · Nature Reviews Drug Discovery Review May 2007 553
13 Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial Daniel D. Mikol, Frederik Barkhof, Peter Chang et al. · The Lancet Neurology 12 Sep 2008 487
14 Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus Sergey V. Kozyrev et al. · Nature Genetics Open access 20 Jan 2008 479
15 Expression and Characterization of the Chemokine Receptors CCR2 and CCR5 in Mice Matthias Mack, Josef Cihak, Christopher Simonis et al. · The Journal of Immunology Apr 2001 474
16 Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment Sofia Gameiro, Jacky Boivin, L. Peronace et al. · Human Reproduction Update ReviewOpen access 6 Aug 2012 461
17 RORγ-Expressing Th17 Cells Induce Murine Chronic Intestinal Inflammation via Redundant Effects of IL-17A and IL-17F Moritz Leppkes, Christoph Becker, Ivaylo I. Ivanov et al. · Gastroenterology Open access 10 Oct 2008 451
18 Resveratrol is Not a Direct Activator of SIRT1 Enzyme Activity Dirk Beher, John Y. J. Wu, Suzanne Cumine et al. · Chemical Biology & Drug Design 20 Oct 2009 426
19 Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study Jean Louis Lefèbvre et al. · Journal of Clinical Oncology Open access 23 Jan 2013 422
20 The antral follicle count: practical recommendations for better standardization Frank J. Broekmans, Dominique de Ziegler, Colin M. Howles et al. · Fertility and Sterility Open access 9 Jul 2009 417
21 IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not Kerstin Wolk, Harald S. Haugen, Wenfeng Xu et al. · Journal of Molecular Medicine 30 Mar 2009 409
22 IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice Stefan Haak, Andrew L. Croxford, Katharina Kreymborg et al. · Journal of Clinical Investigation Open access 15 Dec 2008 403
23 PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond? Christian Rommel, Montserrat Camps, Hong Ji · Nature reviews. Immunology Review 9 Feb 2007 400
24 SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer Guy A. Van Hazel et al. · Journal of Clinical Oncology 22 Feb 2016 352
25 Contemporary genetic technologies and female reproduction The Evian Annual Reproduction (EVAR) Workshop Group 2010, Bart C.J.M. Fauser, K. Diedrich et al. · Human Reproduction Update Open access 6 Sep 2011 348
26 Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers Hans F. A. Vasen et al. · Journal of Clinical Oncology Open access 26 Apr 2016 346
27 Overcoming hurdles in developing successful drugs targeting chemokine receptors Thomas J. Schall, Amanda E. I. Proudfoot · Nature reviews. Immunology Review 15 Apr 2011 325
28 Metformin therapy and clinical uses John H.B. Scarpello, H. C. S. Howlett · Diabetes and Vascular Disease Research Open access 2008 323
29 PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus Domingo Francisco Barber, Almira Bartolomé, Carmen Hernández et al. · Nature Medicine 26 Aug 2005 314
30 Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial) David Alan Isenberg et al. · Annals of the Rheumatic Diseases Open access131 authors 21 Jun 2014 313
31 Nonsupplemented Luteal Phase Characteristics after the Administration of Recombinant Human Chorionic Gonadotropin, Recombinant Luteinizing Hormone, or Gonadotropin-Releasing Hormone (GnRH) Agonist to Induce Final Oocyte Maturation inin VitroFertilization Patients after Ovarian Stimulation with Recombinant Follicle-Stimulating Hormone and GnRH Antagonist Cotreatment Nicole G.M. Beckers, Nicholas Stephen Macklon, Marinus J.C. Eijkemans et al. · The Journal of Clinical Endocrinology & Metabolism Sep 2003 309
32 Fertility knowledge and beliefs about fertility treatment: findings from the International Fertility Decision-making Study Laura Bunting, I. Tsibulsky, Jacky Boivin · Human Reproduction 25 Nov 2012 305
33 Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead Véronique Minard‐Colin et al. · Journal of Clinical Oncology Open access 24 Aug 2015 295
34 Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: Results of a multicenter, phase ib, double‐blind, placebo‐controlled, dose‐escalating trial Maria Dall’Era, Eliza F. Chakravarty, Daniel J. Wallace et al. · Arthritis & Rheumatism 29 Nov 2007 294
35 The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors Alex Berndt, Simon Miller, Olusegun Williams et al. · Nature Chemical Biology Open access 10 Jan 2010 293
36 Randomized trial of safinamide add‐on to levodopa in Parkinson's disease with motor fluctuations Rupam Borgohain, József Attila Szász, Paolo Stanzione et al. · Movement Disorders Open access 9 Dec 2013 292
37 The minimum information required for reporting a molecular interaction experiment (MIMIx) Sandra E. Orchard et al. · Nature Biotechnology Open access Aug 2007 290
38 Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial Ellen M. Ginzler, Stephen D. Wax, Anand Rajeswaran et al. · Arthritis Research & Therapy Open access 7 Feb 2012 286
39 Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1 Kate L. Jeffrey, Tilman Brummer, Michael S. Rolph et al. · Nature Immunology 12 Feb 2006 279
40 Intraarticular Sprifermin (Recombinant Human Fibroblast Growth Factor 18) in Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial Stefan L. Lohmander, Scarlett Hellot, Don Dreher et al. · Arthritis & Rheumatology 17 Apr 2014 277
41 Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial Suzanne Louise Topalian et al. · Journal of Clinical Oncology Open access 23 Apr 2020 276
42 Broadening the horizon – level 2.5 of the HUPO-PSI format for molecular interactions Samuel Kerrien et al. · BMC Biology Open access 9 Oct 2007 276
43 Mitochondrial Cholesterol Contributes to Chemotherapy Resistance in Hepatocellular Carcinoma Joan Montero, Albert Morales, Laura Llacuna et al. · Cancer Research Jul 2008 275
44 Identification of conserved regulatory elements by comparative genome analysis Boris Lenhard, Albin Sandelin, Luis Galindo Mendoza et al. · Journal of Biology Open access 22 May 2003 274
45 Phosphoinositide 3-Kinase p110β Activity: Key Role in Metabolism and Mammary Gland Cancer but Not Development Elisa Ciraolo et al. · Science Signaling Open access 9 Sep 2008 271
46 Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice Marie‐Luise Berres, Rory R. Koenen, Anna Rueland et al. · Journal of Clinical Investigation Open access Nov 2010 265
47 Perfusion mammalian cell culture for recombinant protein manufacturing – A critical review Jean‐Marc Bielser, Moritz Wolf, Jonathan Souquet et al. · Biotechnology Advances Open access 5 May 2018 263
48 Potential of cell retention techniques for large‐scale high‐density perfusion culture of suspended mammalian cells D. Voisard, F. Meuwly, Pierre-Alain Ruffieux et al. · Biotechnology and Bioengineering 11 Apr 2003 261
49 Scoring treatment response in patients with relapsing multiple sclerosis Maria Pia Sormani, Jordi Río, Mar Tintoré et al. · Multiple Sclerosis Journal 25 Sep 2012 260
50 Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis Gavin Giovannoni, Stuart D. Cook, Kottil W Rammohan et al. · The Lancet Neurology 11 Mar 2011 253

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.